| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/25/2001 | CA2379825A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 01/25/2001 | CA2379683A1 Identification of pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379286A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2379041A1 Diacylhydrazine derivatives |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 01/24/2001 | EP1070714A1 Amidine compounds |
| 01/24/2001 | EP1070065A1 Azabicyclic 5ht1 receptor ligands |
| 01/24/2001 | EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors |
| 01/24/2001 | CN1281451A Benzamine derivatives |
| 01/24/2001 | CN1281441A Therapeutically active compounds based on indazole bioisostere replacement of catechol in PDE4 inhibitors |
| 01/24/2001 | CN1281367A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 01/24/2001 | CN1280855A Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose |
| 01/24/2001 | CN1280830A Soft package type enclosed hemodialysis liquid, its special package bag and its application |
| 01/24/2001 | CN1280828A Hemostatic algin powder |
| 01/24/2001 | CN1061042C Adhesion receptor antagonists |
| 01/24/2001 | CN1060942C Mongolian medicine for curing aplastic anemia |
| 01/24/2001 | CN1060939C Traditional Chine medicine preparation for curing microcirculatory disturbance |
| 01/23/2001 | US6177473 Factor x inhibitor |
| 01/23/2001 | US6177470 Prostaglandin synthesis |
| 01/23/2001 | US6177429 Dihydropyrazine derivatives as NPY antagonists |
| 01/23/2001 | US6177426 Morpholino-N-ethyl ester prodrugs of indole sPLA2 inhibitors |
| 01/23/2001 | US6177059 Drugs and complexes with lipids |
| 01/23/2001 | CA2196885C Carboxamide compounds (changed to n-(2-(pyrrolidinyl-1)-1-phenylethyl) acetamides as kappa receptor antagonists) |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004269A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | WO2001004159A1 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 01/18/2001 | WO2001004146A2 Ecarin polypeptides, polynucleotides encoding ecarin, and methods for use thereof |
| 01/18/2001 | WO2001004120A1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 01/18/2001 | WO2001004119A1 Amido spiropiperidines promote the release of growth hormone |
| 01/18/2001 | WO2001004117A1 Heteroaryl protease inhibitors and diagnostic imaging agents |
| 01/18/2001 | WO2001003740A1 Serine protease inhibitor |
| 01/18/2001 | WO2001003737A1 Immunoglobulin fusion proteins |
| 01/18/2001 | WO2001003726A1 Stable factor viii compositions |
| 01/18/2001 | WO2001003720A2 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | WO2001003696A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | WO2001003693A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 01/18/2001 | WO2001003688A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 01/18/2001 | WO2001003669A2 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/18/2001 | WO2000071516A3 INHIBITORS OF FACTOR Xa |
| 01/18/2001 | DE19933173A1 Cyclische Peptidderivate als Inhibitoren des Integrins alpha¶v¶beta¶6¶ Cyclic peptide derivatives as inhibitors of the integrin alpha¶v¶beta¶6¶ |
| 01/18/2001 | DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate |
| 01/18/2001 | CA2381125A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 01/18/2001 | CA2379416A1 Heteroaryl protease inhibitors and diagnostic imaging agents |
| 01/18/2001 | CA2379133A1 Human proteins involved in detoxification |
| 01/18/2001 | CA2378989A1 Human lim domain proteins |
| 01/18/2001 | CA2378567A1 Novel myxoma genes for immune modulation |
| 01/18/2001 | CA2378179A1 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 01/18/2001 | CA2377502A1 Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents |
| 01/18/2001 | CA2340757A1 Delivery of liposomal-encapsulated antioxidants and applications thereof |
| 01/17/2001 | EP1069137A1 Peptides having thrombospondin-like activity and their therapeutic use |
| 01/17/2001 | EP1069132A1 Bicyclic derivatives of amino-pyrazinones, process of preparation and pharmaceutical compositions comprising them |
| 01/17/2001 | EP1069124A1 2-Benzimidazolylamine compounds as ORL1-receptor agonists |
| 01/17/2001 | EP1068322A1 U4, a member of the hematopoietin receptor superfamily |
| 01/17/2001 | EP1068308A1 Secreted proteins and polynucleotides encoding them |
| 01/17/2001 | EP1068221A2 Template associated npy y2-receptor agonists |
| 01/17/2001 | EP1068191A1 Benzoxazinones/benzothiazinones as serine protease inhibitors |
| 01/17/2001 | EP1068190A1 Quinoxalinones as serine protease inhibitors such as factor xa and thrombin |
| 01/17/2001 | EP1068172A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST |
| 01/17/2001 | EP1067953A1 Methods for treating an ischemic disorder and improving stroke outcome |
| 01/17/2001 | EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds |
| 01/17/2001 | EP0730590B1 isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/17/2001 | CN1280586A Erythropoietin with high specific activity |
| 01/17/2001 | CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors |
| 01/17/2001 | CN1280492A Porous hydroxyapatite particles as carriers for drug substances |
| 01/17/2001 | CN1280137A Erythrocyte-stimulating factor coupling |
| 01/17/2001 | CN1279982A Draco nis sanguis micro sponge agent and its preparing technology |
| 01/17/2001 | CN1060673C Medicine for treating nasal hemorrhage |
| 01/16/2001 | US6174993 Short peptides which selectively modulate the activity of serine/threonine kinases |
| 01/16/2001 | US6174890 A synergistic biological, neurometabolic and celltrophic composition comprising antioxidative and -catabolic stress (methionine),-anabolic drugs, vasodilative and normo-lipidemic drugs (nicotinic acid), energoactive and antitoxic |
| 01/16/2001 | US6174863 Carbohydrate derivatives |
| 01/16/2001 | US6174721 Protein having kunitz-type domains of tissue factor pathway inhibitors and lacking glycosylation sites; for prevention and treatment of septic shock |
| 01/16/2001 | US6174539 Localized use of nitric oxide adducts to prevent internal tissue damage |
| 01/16/2001 | CA2314008A1 2-benzimidazolylamine compounds as orl1-receptor agonists |
| 01/16/2001 | CA2200192C Amidino and guanidino substituted inhibitors of trypsin-like enzymes |
| 01/16/2001 | CA1341169C Factor viii analog, process for its preparation and composition containing it |
| 01/11/2001 | WO2001002569A2 Human immune response molecules |
| 01/11/2001 | WO2001002567A1 16405 receptor, a g-protein coupled receptor |
| 01/11/2001 | WO2001002443A1 Heparin compositions that inhibit clot associated coagulation factors |
| 01/11/2001 | WO2001002426A1 A substantially crystalline form of melagatran |
| 01/11/2001 | WO2001002397A1 Tricyclic compounds having spiro union |
| 01/11/2001 | WO2001002381A1 Piperazine derivatives as modulators of chemokine receptor activity |
| 01/11/2001 | WO2001002356A1 Indoline or tetrahydroquinoline derivatives |
| 01/11/2001 | WO2001002029A1 Agent for occluding blood vessels |
| 01/11/2001 | WO2001002017A2 Erythropoietin conjugates with polyethylenglycol |
| 01/11/2001 | WO2001001971A1 Use of cortisol antagonists in the treatment for heat failure |
| 01/11/2001 | WO2001001970A2 New uses potassium channel openers, such as the treatment of epilepsy |
| 01/11/2001 | WO2001001963A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001962A1 A method for the improvement of transport across adaptable semi-permeable barriers |
| 01/11/2001 | WO2001001775A1 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 01/11/2001 | WO2001001749A2 FVIIa ANTAGONISTS |